Localized Adipose Tissue Hypertrophy in Patients Receiving Human Immunodeficiency Virus Protease Inhibitors

Abstract

mal dose of 960 mg daily for the treatment of adenocarci-seen in the future as the life-spans of patients with HIV infection, and therefore the duration of therapy, continue to lengthen. noma of the uterus [9].